Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 4/2001

01-12-2001 | Original article

Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer

Authors: Shinichiro Takahashi, Taira Kinoshita, Masaru Konishi, Toshio Nakagouri, Kazuto Inoue, Masato Ono, Masanori Sugitou, Atsushi Ohtsu, Narikazu Boku, Shigeaki Yoshida

Published in: Gastric Cancer | Issue 4/2001

Login to get access
Metadata
Title
Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer
Authors
Shinichiro Takahashi
Taira Kinoshita
Masaru Konishi
Toshio Nakagouri
Kazuto Inoue
Masato Ono
Masanori Sugitou
Atsushi Ohtsu
Narikazu Boku
Shigeaki Yoshida
Publication date
01-12-2001
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 4/2001
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-001-8009-5

Other articles of this Issue 4/2001

Gastric Cancer 4/2001 Go to the issue

Letter to the editor

Mucinous gastric carcinoma: is it more malignant?

Original article

Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis

Original article

Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study

Editorial

Inclusion in the Index Medicus database

Review article

Surgery for gastric cancer: 10-year experience worldwide

Review article

Adjuvant chemotherapy for gastric cancer: a comprehensive review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits